Skip to main content

Lifeward Ltd.

corporate_fare Company Profile

Lifeward Ltd.

LFWD·NASDAQ·Industrial Applications And Services·CIK 0001607962

ReWalk is a medical device company that designs, develops, and commercializes solutions for physical rehabilitation and recovery. The company's initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices, referred to as SCI Products, for individuals with spinal cord injury. These robotic exoskeletons use patented tilt-sensor technology, an onboard computer, and motion sensors to power motorized legs, enabling individuals with paraplegia to stand and walk. In March 2023, ReWalk received 510(k) clearance from the U.S. FDA for the ReWalk Personal Exoskeleton with stair and curb functionality, allowing U.S. users to navigate stairs and curbs. This feature has been available in Europe since initial CE Clearance, supported by real-world data from 47 European users over seven years, involving over 18,000 stair steps. In March 2025, the company received 510(k) clearance for the ReWalk 7 Personal Exoskeleton device, a next-generation model. ReWalk has also expanded its product offerings beyond SCI Products, including the ReStore Exo-Suit device, which began commercialization in June 2019. The ReStore is a powered, lightweight soft exo-suit designed for the rehabilitation of individuals with lower limb disabilities due to stroke. Sales of the ReStore device in the European Union ceased in May 2024.

Lifeward Ltd. (NASDAQ:LFWD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 47 items for LFWD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for LFWD spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Lifeward Q3 Revenue Falls 12% to $5.4M; Going-Concern Doubt Reaffirmed on $4.5M Cash
  • Lifeward Posts $5.5M Adjusted Loss as Q3 Revenue Hits $5.4M
  • Lifeward Shareholders Clear Exchange Cap Removal; Compensation Policy Voted Down
  • Lifeward CFO Pick Rami Aviram Backs Out Before Start Date
  • Lifeward Seeks Shareholder Approval for Up to 73% Dilution from Convertible Notes and Warrants

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$22.03M
Net Income
-$19.91M
Diluted EPS
-$17.16
Op. Cash Flow
-$16.83M
Free Cash Flow
-$16.84M
Gross Profit
$8.43M
Operating Income
-$19.67M
Cash & Equivalents
$2.17M
Debt / Equity
0.00×
Net Margin
-90.4%
Shares Outstanding
1.52M sh
Source: 10-K · filed 2026-03-18 · accession 0001178913-26-001208

Short Interest & Short Volume

5.01 days to cover

FINRA reported short interest of 87,325 shares in LFWD as of the October 30, 2026 settlement, a 2.6% decrease from the prior period — about 5.0 days to cover at its recent average daily volume. On November 20, 2026, 39.2% of LFWD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)87,325 shares as of October 30, 2026
Change vs prior period▼ 2.6%
Days to cover5.01 at avg daily volume of 17,420
Daily short volume (FINRA facilities)39.2% of 24,513 shares on November 20, 2026
5-day average short volume32.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for LFWD, detected from its recent SEC filings · based on capital-structure filings through 2026-07-07.

1 shelf registration

Secured $5.58M Initial Financing · Potential Additional $5.58M Contingent on Performance

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with L →
$2.8 -4.98% today
52-week range · as of 2026-11-13 $2.8 – $9.61
Market cap
$7.96M
Volume
35.4K (1.7× avg)
3-mo avg 20.7K
Live data · 2026-11-22 12:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LFWD - Latest Insights

LFWD
Nov 13, 2026, 9:22 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.42
Real-time Price: $2.80 info
Change: -$2.62 (-48%) info
Market Cap: $7.957M info
LFWD
Nov 13, 2026, 9:17 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $5.72
Real-time Price: $2.80 info
Change: -$2.92 (-51%) info
Market Cap: $7.957M info
LFWD
Nov 05, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $2.80 info
Change: -$2.94 (-51%) info
Market Cap: $7.957M info
LFWD
Oct 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.43
Real-time Price: $2.80 info
Change: -$3.63 (-56%) info
Market Cap: $7.957M info
LFWD
Sep 25, 2026, 4:45 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.99
Real-time Price: $2.80 info
Change: -$4.19 (-60%) info
Market Cap: $7.957M info
LFWD
Sep 15, 2026, 5:26 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $7.07
Real-time Price: $2.80 info
Change: -$4.27 (-60%) info
Market Cap: $7.957M info
LFWD
Aug 31, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.65
Real-time Price: $2.80 info
Change: -$4.85 (-63%) info
Market Cap: $7.957M info
LFWD
Aug 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.33
Real-time Price: $2.80 info
Change: -$4.53 (-62%) info
Market Cap: $7.957M info
LFWD
Aug 14, 2026, 10:21 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $7.55
Real-time Price: $2.80 info
Change: -$4.75 (-63%) info
Market Cap: $7.957M info
LFWD
Aug 14, 2026, 9:26 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.50
Real-time Price: $2.80 info
Change: -$4.70 (-63%) info
Market Cap: $7.957M info
LFWD
Aug 14, 2026, 9:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.50
Real-time Price: $2.80 info
Change: -$4.70 (-63%) info
Market Cap: $7.957M info
LFWD
Aug 14, 2026, 9:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $7.50
Real-time Price: $2.80 info
Change: -$4.70 (-63%) info
Market Cap: $7.957M info
LFWD
Aug 03, 2026, 9:17 AM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $2.80 info
Change: -$4.20 (-60%) info
Market Cap: $7.957M info
LFWD
Jul 07, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.45
Real-time Price: $2.80 info
Change: -$5.65 (-67%) info
Market Cap: $7.957M info
LFWD
Jul 07, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $8.45
Real-time Price: $2.80 info
Change: -$5.65 (-67%) info
Market Cap: $7.957M info
LFWD
May 20, 2026, 4:24 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $6.49
Real-time Price: $2.80 info
Change: -$3.69 (-57%) info
Market Cap: $7.957M info
LFWD
May 15, 2026, 8:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $7.37
Real-time Price: $2.80 info
Change: -$4.57 (-62%) info
Market Cap: $7.957M info
LFWD
May 15, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.37
Real-time Price: $2.80 info
Change: -$4.57 (-62%) info
Market Cap: $7.957M info
LFWD
May 14, 2026, 5:19 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $6.60
Real-time Price: $2.80 info
Change: -$3.79 (-57%) info
Market Cap: $7.957M info
LFWD
May 14, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $6.17
Real-time Price: $2.80 info
Change: -$3.37 (-55%) info
Market Cap: $7.957M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets